Aragwadha (Cassia fistula): Laxative Evidence, Dosage & Safety

TL;DR

Aragwadha is the fruit pulp of the golden-shower tree (Cassia fistula), Ayurveda's classic mild laxative. Two randomized trials in children with functional constipation found a fruit-pulp emulsion improved bowel frequency and stool consistency, beating mineral oil and matching PEG. Anthraquinones drive the effect; long-term safety is unstudied.

What it is

Aragwadha (also transliterated Aragvadha) is the fruit pulp of Cassia fistula L. (family Leguminosae/Caesalpiniaceae), a tree native to South and Southeast Asia known as the golden shower tree or purging cassia (Mozaffarpur et al., BMC Complement Altern Med 2012). The drug is the pulp of the long cylindrical pods. The laxative activity comes from anthraquinone derivatives in the fruit pulp (same trial).

One thing to file away: everything in the clinical section below is about a specifically prepared emulsion, not raw fruit pulp scooped from a pod. The two are related but not identical, and I will keep saying so.

Traditional use

Aragvadha is one of the fifteen virechana (purgative) drugs named by Sushruta, and Charaka praised it as the mildest of purgatives: considered gentle enough for traditional use in children and the elderly (Planta Medica abstract; Mozaffarpur et al. 2012). Classical indications include constipation and fever, and traditional texts list skin and other disorders among its uses (Planta Medica abstract). Experimental work showed the pulp's sugar-free residue produces a cathartic effect, with mice passing "Senna"-like stools within 4–6 hours (same abstract).

Traditional and animal findings. Not human clinical proof. The trials are next, and I assess them separately.

What modern research says

Functional constipation in children (two randomized trials)

Trial 1: Cassia emulsion vs mineral oil. In an open-label randomized trial, 81 children aged 4–13 years with functional constipation (Rome III criteria) received either a Cassia fistula emulsion (41 children) or mineral oil (40 children) for 3 weeks (Mozaffarpur et al. 2012). After treatment, 84% of the Cassia group versus 50% of the mineral oil group no longer met the diagnostic criteria (p=0.002). Weekly defecation frequency rose from 1.7 to 10.6 with Cassia versus 2.0 to 6.1 with mineral oil (p<0.001). Defecation pain and stool consistency also improved significantly more with Cassia, and oily anal leakage occurred only with mineral oil. No clinically significant side effects were reported (same trial). That is a strong margin against a real comparator, not a sugar pill.

Trial 2: Cassia emulsion vs PEG 4000. A second randomized open-label trial enrolled 109 children aged 2–15 years for 4 weeks. In the Cassia emulsion group, 86.5% exited the functional-constipation criteria versus 77.1% of the PEG 4000 group, and defecation frequency was significantly higher with Cassia (10.96 ± 5.7 vs 6.9 ± 3.5 per week, p<0.0001). Most other outcomes did not differ, compliance was better with PEG in the first two weeks, and no clinically significant side effects were reported (Mirzapour et al., Iran Red Crescent Med J 2016).

Limitations. I don't want the good numbers above to outrun their context. Both trials were open-label, single-center, short (3–4 weeks), and enrolled only children with functional constipation, using a specifically prepared emulsion, not raw fruit pulp. There are no robust trials in adults and no long-term data. Two small pediatric trials is the whole human file.

What the evidence does not support (yet)

Adult constipation efficacy, "detox" or colon-cleanse claims, and the traditional skin-disorder and other indications have not been tested in human trials and remain unproven. The tradition lists a lot of uses. The trials back exactly one of them, in children only.

Dosage

Doses here are research and reference values, not recommendations:

Stimulant laxatives should not be used long-term without medical guidance; the trials lasted only 3–4 weeks and did not assess longer use (Mozaffarpur et al. 2012). Do not dose children yourself. Pediatric constipation needs a clinician's plan.

Safety & contraindications

In the two short pediatric trials (combined ~190 children), no clinically significant side effects were reported (Mozaffarpur et al. 2012; Mirzapour et al. 2016). That establishes short-term tolerability in children. It does not establish long-term safety, which is unstudied. Say those two sentences together, always.

Aragwadha is an anthraquinone (stimulant) laxative, and chronic unmonitored use of stimulant laxatives is inadvisable. The trials give no information about use beyond 4 weeks. Safety in pregnancy and breastfeeding has not been studied: avoid without a clinician. Do not use laxatives for undiagnosed abdominal pain, rectal bleeding, or suspected bowel obstruction without medical evaluation.

FAQs

What is aragwadha?

Aragwadha is the fruit pulp of Cassia fistula (golden shower tree), an Ayurvedic mild laxative, mridu virechana (Mozaffarpur et al. 2012). The trials tested a prepared emulsion of the pulp, not the raw pod contents.

Does aragwadha work for constipation?

In children, the data say yes, with the usual caveats about size and blinding. Two randomized trials in children with functional constipation found a standardized fruit-pulp emulsion improved bowel frequency and stool consistency: better than mineral oil, comparable to PEG 4000 (Mozaffarpur et al. 2012; Mirzapour et al. 2016). There are no robust adult trials. None.

How does aragwadha work?

Its fruit pulp contains anthraquinone derivatives, the same class of compounds behind senna's laxative action, which stimulate bowel movement (Mozaffarpur et al. 2012). Stimulant laxative, in other words, with all the usual cautions that classification carries.

What dose was used in the studies?

The trials used a prepared emulsion equivalent to 0.1 g/kg/day of dried pulp in children: a clinical-trial regimen, not home-dosing advice. No adult clinical-trial or pharmacopoeial dose is given here. And parents should not dose children themselves.

Is aragwadha safe for long-term use?

Unknown. The trials lasted only 3–4 weeks with no clinically significant side effects reported; effects and safety of longer use are unstudied (Mozaffarpur et al. 2012; Mirzapour et al. 2016). Unknown means unknown, not "probably fine."

Can children or pregnant women use aragwadha?

The trials were in children aged 2–15, but parents should not dose children themselves: pediatric constipation needs a clinician's plan. Safety in pregnancy has not been studied; avoid without a clinician.

Sources

The mineral-oil comparison is Mozaffarpur et al.'s 2012 randomized clinical trial of Cassia fistula emulsion against mineral oil in pediatric functional constipation (BMC Complementary and Alternative Medicine; full text). I lean on this one for identity, the anthraquinone mechanism, and the trial data alike. The PEG 4000 comparison is Mirzapour et al.'s 2016 randomized clinical trial of the Cassia fistula emulsion versus polyethylene glycol 4000 in pediatric functional constipation (Iranian Red Crescent Medical Journal; full text). The traditional purgative ranking and the mouse cathartic data come from Iyengar, Pendse, and Narayana's "Aragvadha" (Planta Medica 1966;14(3):289–301, DOI: 10.1055/s-0028-1100056; abstract).

Disclaimer

This article is for educational purposes only and is not medical advice. Herbal products can interact with medications and are not suitable for everyone. Talk to a qualified healthcare practitioner before use, especially if you are pregnant, breastfeeding, managing a medical condition, or taking prescription medicines.